TELEMEDICINE
The Covid-19 pandemic accelerated the adoption of telemedicine in daily clinical practice, enabling new ways of managing patients and bridging physical distances between clinics and communities. Meteda invested in ready-to-use digital solutions integrated with the electronic medical record to ensure continuity of care remotely.
During the Covid emergency, Meteda provided digital tools integrated with the electronic health record to remotely manage people with diabetes unable to attend clinics.
SmartVisit® and SmartLink®: Televisits, Teleconsultations, and Secure Communication
Meteda’s SmartVisit® and SmartLink® devices:
GliConnect®: Diabetes Telemonitoring
GliConnect® is interoperable with electronic medical records, Local Health Administrative Operational Centers, and the Electronic Medical Repositories.
GliConnect® integration with the electronic medical record allows patient device data to be linked to the individual’s clinical-therapeutic history.
GliConnect®'s integration with the electronic medical record is crucial for a comprehensive set of values recorded by remote devices along with the individual patient's clinical, diagnostic, and therapeutic history. This workflow ensures a telemonitoring function that complies with the criteria outlined in Annex B of the Ministerial Decree of September 30, 2022. Therefore, it is of practical importance to export it through continuous communication processes and integration with the Regional Telemedicine Infrastructures that the various regional bodies are required to set up and then communicate with the FSE and PNT.